Table 1.
Case Number |
Diagnosis | CI in WSI | CI in WBI | ||
---|---|---|---|---|---|
Foci | Morphology | Foci | Morphology | ||
1 | PTC-CV | 5 | SN, POE | 12 | SN, POE |
2 | HCC | 3 | SN, POE | 8 | SN, POE |
3 | HCC | 2 | SN | 2 | SN |
4 | HCC | 2 | POE | 2 | POE |
5 | PTC-EFV | 1 | POE | 1 | SN |
6 | FTC | 1 | POE | 1 | POE |
7 | FTC | 1 | SN | 1 | SN |
8 | PTC-CV | 1 | POE | 1 | POE |
9 | PTC-CV | 1 | SN | 1 | POE |
10 | HCC | 1 | SN | 1 | POE |
11 | NIFTP | 0 | Incomplete penetration | 0 | Incomplete penetration |
PTC-CV: papillary thyroid carcinoma, classic variant, HCC: Hurthle cell carcinoma, PTC-EFV: papillary thyroid carcinoma, encapsulated follicular variant, FTC: follicular thyroid carcinoma, NIFTP: noninvasive follicular thyroid neoplasm with papillary-like nuclear features, SN: satellite nodule, POE: point of entry (point of penetration).